F
Frida Stock
Researcher at National Institutes of Health
Publications - 48
Citations - 3687
Frida Stock is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Pneumocystis carinii & Chronic granulomatous disease. The author has an hindex of 29, co-authored 48 publications receiving 3415 citations. Previous affiliations of Frida Stock include United States Department of Health and Human Services.
Papers
More filters
Journal ArticleDOI
Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing
Evan S. Snitkin,Adrian M. Zelazny,Pamela J. Thomas,Frida Stock,David K. Henderson,Tara N. Palmore,Julia A. Segre +6 more
TL;DR: Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing revealed its origin and probable modes of transmission, and revealed the weaknesses in this medical who-done-it, informing improvements in hospital preventive measures.
Journal ArticleDOI
Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma
John F. Toso,Vee J. Gill,Patrick Hwu,Francesco M. Marincola,Nicholas P. Restifo,Douglas J. Schwartzentruber,Richard M. Sherry,Suzanne L. Topalian,James Chih-Hsin Yang,Frida Stock,Linda J. Freezer,Kathleen E. Morton,Claudia A. Seipp,Leah R. Haworth,Sharon Mavroukakis,Donald E. White,Susan MacDonald,John Mao,M Sznol,Steven A. Rosenberg +19 more
TL;DR: The VNP20009 strain of Salmonella typhimurium can be safely administered to patients, and at the highest tolerated dose, some tumor colonization was observed.
Journal ArticleDOI
Lysis—centrifugation blood cultures in the detection of tissue-proven invasive candidiasis disseminated versus single-organ infection
TL;DR: The sensitivity of LC blood cultures in the detection of tissue-proven invasive candidiasis was investigated, finding no difference in colonies of organisms per LC tube between patients with DI and those with SO.
Journal ArticleDOI
Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii
Adrian M. Zelazny,Jeremy M. Root,Yvonne R. Shea,Rhonda E Colombo,Isdore Chola Shamputa,Frida Stock,Sean Conlan,Steven McNulty,Barbara A. Brown-Elliott,Richard J. Wallace,Kenneth N. Olivier,Steven M. Holland,Elizabeth P. Sampaio +12 more
TL;DR: An extensive molecular identification and typing of 42 clinical isolates of M. abscessus, M. massiliense, and M. bolletii from patients monitored at the NIH between 1999 and 2007 found that the clinical manifestations of disease caused by each species were similar.
Journal ArticleDOI
Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii
Evan S. Snitkin,Adrian M. Zelazny,Clemente I. Montero,Frida Stock,Lilia A. Mijares,Patrick R. Murray,Julie A. Segre,Jim C. Mullikin,Robert W. Blakesley,Alice Young,Grace Chu,Colleen Ramsahoye,Sean Lovett,Joel Han,Richelle Legaspi,Christina Sison,Michael D. Gregory,Casandra Montemayor,Marie Gestole,April Hargrove,Taccara Johnson,Jerlil Myrick,Nancy Riebow,Brian L. Schmidt,Betsy Novotny,Jyoti Gupta,Betty Benjamin,Shelise Brooks,Holly Coleman,Shi-ling Ho,Karen Schandler,Lauren H. Smith,Mal Stantripop,Quino Maduro,Gerry Bouffard,Mila Dekhtyar,Xiaobin Guan,Cathy Masiello,Baishali Maskeri,Jenny McDowell,Morgan Park,Pam Thomas +41 more
TL;DR: A genomic study of a polyclonal outbreak of multidrug-resistant A. baumannii found the simultaneous presence of three divergent strains from this lineage supports its increasing prevalence in international hospitals and suggests an ongoing adaptation to the hospital environment.